Poster Presentation 20th Lancefield International Symposium on Streptococci and Streptococcal Diseases 2017

Differences in SpeB protease activity among group A streptococci associated with superficial, invasive, and autoimmune disease (#208)

Anhphan T Ly 1 , John P Noto 1 , Odaelys L Walwyn 1 , Robert R Tanz 2 , Stanford T Shulman 2 , William Kabat 2 , Herve Tettelin 3 , Debra Bessen 1
  1. Microbiology and Immunology, New York Medical College, Valhalla, New York, USA
  2. Pediatrics, Northwestern University Feinberg School of Medicine and Ann & Robert H. Lurie Children's Hospital, Chicago, Illinois, USA
  3. Microbiology & Immunology, Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, Maryland, USA

The secreted cysteine proteinase SpeB is an important virulence factor of group A streptococci (GAS), whereby SpeB activity varies widely among strains. To establish the degree to which SpeB activity correlates with disease, GAS organisms were recovered from patients with pharyngitis, impetigo, invasive disease or acute rheumatic fever (ARF), and selected for analysis using rigorous sampling criteria; >300 GAS isolates were tested for SpeB activity by casein digestion assays, and each GAS isolate was scored as a SpeB-producer or non-producer. Highly significant statistical differences (p < 0.01) in SpeB production are observed between GAS recovered from patients with ARF (41.5% SpeB-non-producers) compared to pharyngitis (20.5%), invasive disease (16.7%), and impetigo (5.5%). SpeB activity differences between pharyngitis and impetigo isolates are also significant, whereas pharyngitis versus invasive isolates show no significant difference. The disproportionately greater number of SpeB-non-producers among ARF-associated isolates may indicate an altered transcriptional program for many rheumatogenic strains and/or a protective role for SpeB in GAS-triggered autoimmunity. Comparative transcriptomics and qRT-PCR are used to evaluate the relative RNA transcript levels of virulence genes between different GAS isolates in accordance with disease.